CTMX filings
Corporate insider profile
Christopher Ogden Filing Activity
Latest reported as Chief Financial Officer of CytomX Therapeutics, Inc. (CTMX).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$4,953.20
- Latest transaction
- Jun 15, 2026
Affiliated corporations
Reported company relationships
Transaction history
